Current Pharmacogenomics and Personalized Medicine
Title:Editorial (Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches – Per Ardua Ad Astra?)
Volume: 11 Issue: 1
Author(s): Ana Konvalinka, Sanjeeva Srivastava and Mario Masellis
Affiliation:
Keywords: Idiopathic membranous nephropathy, personalized medicine, proteomics, public health pharmacogenomics, renal pharmacogenomics
Export Options
About this article
Cite this article as:
Konvalinka Ana, Srivastava Sanjeeva and Masellis Mario, Editorial (Taking the Kidney Personally: The Quest for Novel Antigens of Idiopathic Membranous Nephropathy through Proteomic Approaches – Per Ardua Ad Astra?), Current Pharmacogenomics and Personalized Medicine 2013; 11 (1) . https://dx.doi.org/10.2174/1875692111311010002
DOI https://dx.doi.org/10.2174/1875692111311010002 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry Understanding Heterogeneity in Supplementation Effects of Selenium in Men: A Study of Stratification Variables and Human Genetics in a Prospective Sample from New Zealand
Current Pharmacogenomics and Personalized Medicine High Glucose Enhances Neurotoxicity and Inflammatory Cytokine Secretion by Stimulated Human Astrocytes
Current Alzheimer Research DNA Damage and Repair in Alzheimers Disease
Current Alzheimer Research Therapeutic Implications of Immunoparalysis in Critically Ill Patients
Inflammation & Allergy - Drug Targets (Discontinued) Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Arterial Dilatation-Related Diseases: The Prerequisite Condition of Arterial Elastic Tissue Damage and Endovascular Treatment
Recent Patents on Medical Imaging Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
Current Pharmaceutical Design Apolipoprotein E4 Serum Concentration for Increased Sensitivity and Specificity of Diagnosis of Drug Treated Alzheimer’s Disease Patients vs. Drug Treated Parkinson’s Disease Patients vs. Age-matched Normal Controls
Current Alzheimer Research Macrophages: Promising Targets for the Treatment of Atherosclerosis
Current Vascular Pharmacology Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4
CNS & Neurological Disorders - Drug Targets Psychological Distress Among Youth Probationers: Using Social Determinants of Health to Assess Suicidal Thoughts and Behaviors
Adolescent Psychiatry Risk Factors for Aphasia in Cerebral Small Vessel Diseases
Current Neurovascular Research Fragile X Syndrome and Autism: Common Developmental Pathways?
Current Pediatric Reviews The Association between Migratory Factors and Emotional and Behavioural Symptoms in Very Recently Arrived Immigrant and Refugee Adolescents
Adolescent Psychiatry Undesired Neural Side-Effects of a Drug, a Chemical and Genetic Interrelated Problem
Central Nervous System Agents in Medicinal Chemistry Editorial [Hot Topic: Naked Plasmid DNA for Gene Therapy (Guest Editors: Munehisa Shimamura & Ryuichi Morishita)]
Current Gene Therapy HLA-G and Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Editorial [Hot Topic: Latest Developments in the Treatment of Inflammatory Disease (Guest Editor: David Fairlie)]
Current Medicinal Chemistry